This page shows the latest gene-editing news and features for those working in and with pharma, biotech and healthcare.
Vertex/CRISPR Therapeutics make headway in sickle cell and beta thalassaemia. Also presenting data at ASH were Vertex and CRISPR Therapeutics, whose gene-editing therapy CTX001 scored some promising results in ... bluebird bio’s beta thalassaemia gene
The new cell and gene therapy platform will house both AskBio and another of Bayer’s recently acquired firms, BlueRock Therapeutics, under one roof. ... BlueRock was established in late 2016 with $225m in start-up funding from Bayer and investment firm
Precision’s ARCUS genome editing platform could deliver ‘safer, more specific gene edits’ through the use of a naturally occurring gene editing enzyme known as endonuclease I-CreI, according to the ... We look forward to working with Lilly to
Biotech agrees to separate deals for the development of gene-editing and mRNA therapies. ... the use of gene editing in lung cells,” said Stéphane Bancel, chief executive officer of Moderna.
it is superseded by one-shot gene therapies coming through development. ... The Danish drugmaker was a latecomer to the gene therapy field but has attempted to catch up with an agreement last year with Bluebird Bio focusing on gene-editing drugs for
Nevertheless, it has encouraged research into therapies that might help patients, such as using gene-editing drugs to splice resistance genes into white blood cells.
More from news
Approximately 6 fully matching, plus 52 partially matching documents found.
gene-editing specialist Sangamo for rights to tau-targeting drug ST-501 as part of a broader R&D alliance. ... Such a shift has recently happened in the gene therapy space, which was a backwater pursued largely by biotech until the progress of companies
The next phases were to enrich the pipeline with acquisitions and partnerships, including a headline deal with blue-bird bio for next generation gene editing that could lead to a potential ... We also have a stem cell platform, gene editing, an exquisite
There are huge implications for communications. Take gene editing, for example. ... We’re going to get to the point where treatments like gene therapies will be ubiquitous – so we need to set ourselves up for them now and embrace the ethical debate
Europe is the test ground for the gene therapy pioneer’s outcomes-based model, which could set the standard for the emerging sector. ... These include pipeline gene-editing therapies from Sanofi and luspatercept from Celgene to name but a few, although
A gene therapy cure for all the world’s CF patients would be a truly remarkable achievement. ... These include alpha-1 antitrypsin deficiency and focal segmental glomerulosclerosis. It’s also working with CRISPR Therapeutics on phase 1/2 clinical
More from intelligence
Approximately 2 fully matching, plus 14 partially matching documents found.
In these roles, Rhodes was responsible for commercialising the company's genome editing technologies as well as driving its research and development. ... Biosciences. Foy said: “With his deep understanding of the gene-editing landscape and extensive
He becomes chief financial officer. CRISPR Therapeutics has appointed Marc Becker as its new chief financial officer with remit to drive development of its gene-editing technology platform.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
A number of current therapeutic approaches – such as gene editing, gene therapy, and stem-cell therapy – were not in existence when many healthcare professionals (HCPs) underwent their training, so there is
After reading this headline, it’s easy to assume that some form of gene editing has led to a cure for HIV. ... Should you read on, you would also discover that gene-editing was in no way used in this treatment.
J. Leading UK health scientists, universities and national research institutions will provide insight into the UK life sciences sector, and their work in ageing, gene editing and artificial intelligence.
Novel technologies, coupled with programmes designed to drive cell and gene research and development, are ushering in a new era of therapies. ... It’s such a disruptive advancement – it’s just incredible to think it has all been made feasible
The emerging technologies revolutionising the biotech industry – from immunotherapy breakthroughs to cutting-edge gene editing techniques.
More from PMHub
Approximately 0 fully matching, plus 5 partially matching documents found.
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education...